-
Biotin-16-UTP RNA Labeling Workflow
2026-08-11
Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating affinity-tagged RNA during in vitro transcription, supporting RNA detection and purification and downstream binding assays. It is intended for controlled research workflows only, not diagnostic or medical use, and requires cold storage and empirical optimization for each polymerase and RNA template.
-
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-11
A 2025 study identifies an AhR–RBX1/HSF1 regulatory axis that links macrophage behavior, pancreatic acinar-cell stress, and tight-junction preservation during severe acute pancreatitis. Its combination of mouse modeling, primary-cell experiments, protein-interaction analysis, and pharmacological perturbation provides a mechanistic framework for studying epithelial barrier injury, while also highlighting unresolved questions about HSF1 regulation.
-
Olaparib: From PARP Trapping to Nascent-Strand Repair
2026-08-10
Olaparib and AZD2281 are examined through a replication-focused lens, connecting PARP trapping with BRCA2-dependent nascent-strand maturation. Learn how this 2026 finding can improve DNA damage response assay design, BRCA-associated cancer research, and radiosensitization studies.
-
DOTAP for Nucleic Acid Delivery and Immune Assays
2026-08-09
DOTAP combines electrostatic nucleic acid binding with adaptable liposomal delivery, making it useful for transient gene expression, functional genomics, and formulation screening. This workflow-focused guide shows how to apply it to immune-metabolism assays inspired by recent nano-zoledronate research while separating established product behavior from exploratory hypotheses.
-
BFH772 (VEGFR2 inhibitor): Lab Guide
2026-08-08
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis, including biochemical, cellular, and tumor-model workflows. It is suited to organic-solvent formulations and selectivity-focused experiments, but should not be used when a water-soluble compound, broad kinase inhibition, or an established clinical dosing protocol is required.
-
Isradipine (Dynacirc): L-Type Assay Logic
2026-08-07
Isradipine (Dynacirc) is examined here as an L-type calcium-channel probe rather than simply an antihypertensive compound. Learn how to interpret its vascular and neuronal effects alongside the subtype-selectivity findings of Sidach and Mintz.
-
DiscoveryProbe Protease Inhibitor Library: Translational Wor
2026-08-07
Harness the DiscoveryProbe Protease Inhibitor Library for robust, high throughput screening in apoptosis, cancer, and infectious disease research. This guide demystifies experimental setup, workflow optimization, and troubleshooting, directly linking the library’s capabilities to cutting-edge translational applications.
-
Latrunculin B in Translational Actin Dynamics: Evidence, Str
2026-08-06
Explore how Latrunculin B, a validated actin polymerization inhibitor, enables precise, transient disruption of the cytoskeleton for advanced cellular actin dynamics research. This thought-leadership article integrates mechanistic insights, strategic experimental guidance, and recent virological evidence to inform translational investigators seeking to leverage actin cytoskeleton manipulation for next-generation discovery.
-
Synergistic Apoptosis and Pyroptosis in RCC via SGI-1027 and
2026-08-06
This study demonstrates that combining SGI-1027, a DNMT1 inhibitor, with everolimus induces robust apoptosis and GSDME-dependent pyroptosis by triggering lysosomal membrane permeability in renal cell carcinoma (RCC) cells. These findings provide a new therapeutic approach for overcoming everolimus resistance in advanced RCC.
-
8-Chloroadenosine: Elevating RNA Metabolism Study Protocols
2026-08-05
8-Chloroadenosine stands out as a high-purity nucleoside analog for precise inhibition of RNA synthesis, streamlining experimental workflows in transcriptional regulation research. Its robust solubility profile and validated performance make it essential for dissecting complex lncRNA-mediated mechanisms in cancer studies.
-
Dantrolene Sodium Salt: Precision Ryanodine Receptor Antagon
2026-08-05
Dantrolene sodium salt, a nanomolar-potency ryanodine receptor antagonist, delivers precise, calmodulin-dependent control of intracellular calcium signaling for disease models and CRISPR workflows. This guide translates bench research into actionable protocols, troubleshooting, and next-generation applications for calcium-driven assays and synthetic lethality screens.
-
Strategic Protease Inhibition: From Mechanism to Translation
2026-08-04
This article provides translational researchers with a strategic, evidence-driven exploration of protease inhibition, bridging mechanistic insights with real-world guidance. By analyzing the DiscoveryProbe Protease Inhibitor Library’s role in high-throughput screening and mechanistic studies, and integrating recent advances in HIV-1 protease autoprocessing, we illuminate new opportunities for drug discovery and disease modeling.
-
Maraviroc (UK-427857): Applied CCR5 Antagonism in HIV & Stro
2026-08-04
Maraviroc (UK-427857) empowers researchers to dissect CCR5-driven mechanisms in HIV-1 entry and neuroinflammation, providing nanomolar efficacy and proven selectivity. This article distills protocol best practices, cross-domain applications, and troubleshooting guidance to maximize the value of APExBIO's Maraviroc in advanced translational workflows.
-
Triptolide (PG490): Precision Inhibitor for Cancer Research
2026-08-03
Triptolide (PG490) from APExBIO is a nanomolar-potency inhibitor that revolutionizes workflows in cancer biology and immunology. Its multi-pathway mechanism enables precise control over transcription, invasion, and apoptosis, making it indispensable for advanced cell-based and in vivo studies.
-
Viral Degradation of RIPK3: Proteasome Control of Necroptosi
2026-08-03
Liu et al. (2021) identify a class of orthopoxvirus-encoded proteins that induce targeted degradation of the necroptosis adaptor RIPK3 via the host ubiquitin-proteasome system. This mechanism reveals a pivotal viral immune evasion strategy and highlights new avenues for studying proteasome-mediated regulation of inflammation and cell death.